Colorectal Cancer, Lung Cancer, Multiple Myeloma, Non Hodgkin Lymphoma
Conditions
Keywords
Cancer, Vagus nerve stimulation, Heart rate variability, Osteopathy
Brief summary
In France, new cancer cases keep on increasing with around 150 000 deaths yearly. Cancer therapy research is constantly evolving. Indeed, several studies explore new treatments or their combination with conventional cancer treatments. But, at the same time, complementary and alternative medicines, as osteopathy, remain little explored upon their role in the combination with conventional therapy. Several studies showed indirect interaction between vagus nerve and cancer. Firstly, vagus nerve regulates homeostasis and immunity by reducing systemic inflammation while maintaining local inflammation and antitumor effects. Secondly, vagus nerve stimulation increases Heart Rate Variability (HRV). Moreover, a higher HRV is associated with an improvement of vital prognosis in cancer patients. Vagus nerve could be stimulated by noninvasive osteopathic manipulations. This prospective, monocentric and randomized study is a collaboration between the Centre Hospitalier d'Avignon and the Institut de Formation en Ostéopathie du Grand Avignon. It focuses on using noninvasive osteopathic mobilizations to stimulate vagus nerve. Indeed, this study aims to evaluate effects of vagus nerve osteopathic stimulations on HRV in patients with lung cancer, colorectal cancer, Non Hodgkin Lymphoma or Multiple Myeloma. More specifically, this study will tell us whether vagus nerve noninvasive osteopathic stimulations induce increase of HRV associated with a decrease of systemic inflammation and an improvement of patient's quality of life.
Interventions
Nerve vagus stimulation
BIOLOGICALCRP assessment
Blood CRP will be assessed during trial
BEHAVIORALQLQ-C30 questionnaire
Completion of QLQ-C30
Sponsors
Institut de Formation en Ostéopathie du Grand Avignon
Centre Hospitalier Henri Duffaut - Avignon
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Intervention model description
For each cancer type, 30 patients will be included. These patients will be randomized into two groups.
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patient with lung cancer or colorectal cancer or Non Hodgkin Lymphoma or Multiple Myeloma (Stade I à IV) * No previous treatment * HRV \< 70 ms * No osteopathic contraindication
Exclusion criteria
* Vagotomy * Heart arrhythmia * Cancer recurrence * Consumption of coffee or tabac within 2 hours prior osteopathic treatment * Consumption of alcohol within 24 hours prior osteopathic treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change of Heart Rate Variability measured by SDNN (Standard Deviation of all NN intervals) from baseline to the end of osteopathic treatment | up to 84 days | To assess the effect of vagus nerve osteopathic stimulations on Heart Rate Variability |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Serum concentration of C-Reactive Protein | up to 84 days | To assess the effect of vagus nerve osteopathic stimulations on systemic inflammatory |
| Time to definitive improvement in global health status / QoL | up to 84 days | To assess the effect of vagus nerve osteopathic stimulations on health related quality of life |
Countries
France
Outcome results
None listed